$11.99
0.433.72%
Pre-Market: 4:31 AM EDT
Comments
Loading...
Alvotech Analyst Ratings and Price Targets | NASDAQ:ALVO | Benzinga
Alvotech has a consensus price target of $13.6 based on the ratings of 5 analysts. The high is $18 issued by UBS on February 14, 2025. The low is $10 issued by Citigroup on October 20, 2023. The 3 most-recent analyst ratings were released by UBS, Barclays, and Barclays on February 14, 2025, July 25, 2024, and May 24, 2024, respectively. With an average price target of $19.33 between UBS, Barclays, and Barclays, there's an implied 61.25% upside for Alvotech from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
UBS
Barclays
Citigroup
Deutsche Bank
Morgan Stanley
1calculated from analyst ratings
Analyst Ratings for Alvotech
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 02/14/2025 | Buy Now | 50.13% | UBS | — | → $18 | Initiates | → Buy | Get Alert |
| 07/25/2024 | Buy Now | 50.13% | Barclays | Balaji Prasad53% | $22 → $18 | Maintains | Overweight | Get Alert |
| 05/24/2024 | Buy Now | 83.49% | Barclays | Balaji Prasad53% | $20 → $22 | Maintains | Overweight | Get Alert |
| 03/22/2024 | Buy Now | 66.81% | Barclays | Balaji Prasad53% | $17 → $20 | Maintains | Overweight | Get Alert |
| 01/29/2024 | Buy Now | 41.78% | Barclays | Balaji Prasad53% | $10 → $17 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 10/20/2023 | Buy Now | -16.6% | Citigroup | Andrew Baum72% | $5 → $10 | Upgrade | Sell → Neutral | Get Alert |
| 09/21/2023 | Buy Now | -16.6% | Barclays | Balaji Prasad53% | → $10 | Initiates | → Equal-Weight | Get Alert |
| 03/07/2023 | Buy Now | 0.08% | Deutsche Bank | Emmanuel Papadakis48% | $8 → $12 | Maintains | Hold | Get Alert |
| 09/07/2022 | Buy Now | -16.6% | Morgan Stanley | Thibault Boutherin1% | → $10 | Initiates | → Equal-Weight | Get Alert |
| 09/06/2022 | Buy Now | -58.3% | Citigroup | Andrew Baum72% | $12 → $5 | Downgrade | Buy → Sell | Get Alert |
| 07/26/2022 | Buy Now | 0.08% | Citigroup | Andrew Baum72% | → $12 | Initiates | → Buy | Get Alert |
| 07/01/2022 | Buy Now | -16.6% | Deutsche Bank | Emmanuel Papadakis48% | → $10 | Initiates | → Hold | Get Alert |
FAQ
What is the target price for Alvotech (ALVO) stock?
The latest price target for Alvotech (NASDAQ:ALVO) was reported by UBS on February 14, 2025. The analyst firm set a price target for $18.00 expecting ALVO to rise to within 12 months (a possible 50.13% upside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Alvotech (ALVO)?
The latest analyst rating for Alvotech (NASDAQ:ALVO) was provided by UBS, and Alvotech initiated their buy rating.
When was the last upgrade for Alvotech (ALVO)?
The last upgrade for Alvotech happened on January 29, 2024 when Barclays raised their price target to $17. Barclays previously had an equal-weight for Alvotech.
When was the last downgrade for Alvotech (ALVO)?
The last downgrade for Alvotech happened on September 6, 2022 when Citigroup changed their price target from $12 to $5 for Alvotech.
When is the next analyst rating going to be posted or updated for Alvotech (ALVO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Alvotech, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Alvotech was filed on February 14, 2025 so you should expect the next rating to be made available sometime around February 14, 2026.
Is the Analyst Rating Alvotech (ALVO) correct?
While ratings are subjective and will change, the latest Alvotech (ALVO) rating was a initiated with a price target of $0.00 to $18.00. The current price Alvotech (ALVO) is trading at is $11.99, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.